Skip to content

Ensysce Biosciences, Inc.

Public company
Headquarters
LA JOLLA, California
Ticker
ENSC
CIK
0001716947

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

4
3 appointments, 1 departure

Last event

Nov 4, 2026
Executive appointmentCOO appointed: Lynn Kirkpatrick

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
COOLynn KirkpatrickNov 4, 2026Appointed
CEOJames MorrissonNov 4, 2026Appointed
PresidentLynn KirkpatrickAug 6, 2026Departed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    COO appointed: Lynn Kirkpatrick

    Lynn Kirkpatrick was named Chief Operating Officer of Ensysce Biosciences, Inc.. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Operating Officer

    Source: SEC 8-K, filed Nov 4, 2026

  2. Executive appointment

    CEO appointed: James Morrisson

    James Morrisson was named Chief Executive Officer of Ensysce Biosciences, Inc.. James Morrisson succeeds Lynn Kirkpatrick. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer

    Source: SEC 8-K, filed Nov 4, 2026

  3. Executive departure

    President departs: Lynn Kirkpatrick

    Lynn Kirkpatrick, President of Ensysce Biosciences, Inc., resigns the role, effective August 5, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: President

    Source: SEC 8-K, filed Aug 6, 2026

  4. Executive appointment

    President appointed: James Morrison

    James Morrison was named President of Ensysce Biosciences, Inc., effective August 5, 2026. James Morrison succeeds Lynn Kirkpatrick. The company reported the change in an 8-K that cites Item 5.02.

    Role: President

    Source: SEC 8-K, filed Aug 6, 2026

Last verified Nov 8, 2026